CD79B and diffuse large B-cell lymphoma: (24) studied 574 DLBCL biopsy samples using exome and transcriptome sequencing and identified four prominent genetic subtypes in DLBCL, one of which was termed “MCD” (based on the co-occurrence of MYD88L265P and CD79B mutations).